1. Market Definition & Scope
1.1. Market Definition
1.2. Market Coverage
1.3. Market Ecosystem
1.4. Currency and Limitations
1.5. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Sizing and Forecasting
2.3.1. Market Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Key Factors Affecting Market Growth
4.2.1. Impact Analysis of DROC
4.2.1.1. Increasing Focus on Preventive Healthcare and Self-testing is Driving the Market
4.2.1.2. Data Privacy Concerns Associated with Digital Therapeutics Applications are Restraining Market Growth
4.2.1.3. Emerging Economies and Growing Product Pipeline is Providing Opportunities for Market Growth
4.2.1.4. Lengthy and Tedious Regulatory Approval Process is Posing a Challenge to the Market’s Growth
4.3. Trends
4.3.1. Partnership of Digital Therapeutics Companies with Pharmaceutical Companies
4.3.2. Integration of Artificial Intelligence (AI) in Digital Therapeutics
4.4. Regulatory and Reimbursement Approval Pathway
4.4.1. U.S.
4.4.2. Germany
4.4.3. France
4.4.4. Belgium
4.4.5. U.K.
4.4.6. China
4.4.7. Japan
4.4.8. South Korea
4.5. Case Study
4.5.1. Connected Inhalers to Reduce Asthma Symptoms (Propeller Health)
4.5.2. Sharp Rees-Stealy Medical Group (U.S.) Improves Outcomes with Diabetes Management Program
4.5.3. Improvement in Self-management of Diseases with Digital Health Solutions
5. Digital Therapeutics Market Assessment—by Type
5.1. Overview
5.2. Disease Management and Treatment DTx
5.3. Disease Prevention DTx
6. Digital Therapeutics Market Assessment—by Application
6.1. Overview
6.2. Mental Health
6.3. Diabetes
6.4. Cardiovascular Diseases
6.5. Gastrointestinal Disorders
6.6. Neurology
6.7. Rehabilitation & Patient Care
6.8. Respiratory Disorders
6.9. Oncology
6.10. Addiction Management
6.11. Sleep Disorders
6.12. Smoking Cessation
6.13. Other Applications
7. Digital Therapeutics Market Assessment—by End Users
7.1. Overview
7.2. Providers
7.3. Individual Consumers
7.4. Employers
7.5. Payers
7.6. Other End Users
8. Digital Therapeutics Market Assessment—by Geography
8.1. Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. U.K.
8.3.3. France
8.3.4. Italy
8.3.5. Spain
8.3.6. Rest of Europe (RoE)
8.4. Asia-Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. Rest of Asia-Pacific (RoAPAC)
8.5. Latin America
8.5.1. Brazil
8.5.2. Mexico
8.5.3. Rest of Latin America (RoLATAM)
8.6. Middle East & Africa
9. Competition Analysis
9.1. Introduction
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.4. Competitive Dashboard
9.4.1. Industry Leaders
9.4.2. Market Differentiators
9.4.3. Vanguards
9.4.4. Emerging Companies
9.5. Company Ranking for Global Digital Therapeutics Market (2022)
10. Company Profiles (Company Overview, Financial Snapshot, Product Portfolio, Strategic Developments, SWOT Analysis)
10.1. ResMed Inc.
10.2. Teladoc Health, Inc.
10.3. Noom, Inc.
10.4. DarioHealth Corp.
10.5. GAIA AG
10.6. Biofourmis Inc.
10.7. Virta Health Corp.
10.8. Welldoc, Inc.
10.9. Glooko, Inc.
10.10. 2Morrow Inc.
10.11. Canary Health
10.12. BigHealth
10.13. Akili, Inc.
10.14. Limbix Health, Inc.
10.15. Kaia Healthcare Software Inc.
10.16. Popular Mentions
11. Appendix
11.1. Available Customization
11.2. Related Reports
List of Tables
Table 1 Key Differences Between Digital Health, Digital Medicine, And Digital Therapeutics
Table 2 Market Authorizations of Digital Therapeutics
Table 3 Global Digital Therapeutics Market, by Type, 2021-2030 (USD Million)
Table 4 Global Digital Therapeutics Market for Disease Management and Treatment, by Country/Region, 2021–2030 (USD Million)
Table 5 Global Digital Therapeutics Market for Disease Prevention, by Country/Region, 2021–2030 (USD Million)
Table 6 Global Digital Therapeutics Market, by Applications, 2021-2030 (USD Million)
Table 7 Global Digital Therapeutics Market for Mental Health, by Country/Region, 2021–2030 (USD Million)
Table 8 Global Digital Therapeutics Market for Diabetes, by Country/Region, 2021–2030 (USD Million)
Table 9 Global Digital Therapeutics Market for Cardiovascular Diseases, by Country/Region, 2021–2030 (USD Million)
Table 10 Global Digital Therapeutics Market for Gastrointestinal Disorders, by Country/Region, 2021–2030 (USD Million)
Table 11 Global Digital Therapeutics Market for Neurology, by Country/Region, 2021–2030 (USD Million)
Table 12 Global Digital Therapeutics Market for Rehabilitation and Patient Care, by Country/Region, 2021–2030 (USD Million)
Table 13 Global Digital Therapeutics Market for Oncology, by Country/Region, 2021–2030 (USD Million)
Table 14 Global Digital Therapeutics Market for Respiratory Disorders, by Country/Region, 2021–2030 (USD Million)
Table 15 Global Digital Therapeutics Market for Addiction Management, by Country/Region, 2021–2030 (USD Million)
Table 16 Global Digital Therapeutics Market for Sleep Disorder, by Country/Region, 2021–2030 (USD Million)
Table 17 Global Digital Therapeutics Market for Smoking Cessation, by Country/Region, 2021–2030 (USD Million)
Table 18 Global Digital Therapeutics Market for Other Applications, by Country/Region, 2021–2030 (USD Million)
Table 19 Global Digital Therapeutics Market, by End User, 2021–2030 (USD Million)
Table 20 Global Digital Therapeutics Market for Providers, by Country/Region, 2021–2030 (USD Million)
Table 21 Global Digital Therapeutics Market for Individual Consumers, by Country/Region, 2021–2030 (USD Million)
Table 22 Global Digital Therapeutics Market for Employers, by Country/Region, 2021–2030 (USD Million)
Table 23 Global Digital Therapeutics Market for Payers, by Country/Region, 2021–2030 (USD Million)
Table 24 Global Digital Therapeutics Market for Other End Users, by Country/Region, 2021–2030 (USD Million)
Table 25 Digital Therapeutics Market, by Country/Region, 2021–2030 (USD Million)
Table 26 North America: Digital Therapeutics Market, by Country/Region, 2021–2030 (USD Million)
Table 27 North America: Digital Therapeutics Market, by Type, 2021–2030 (USD Million)
Table 28 North America: Digital Therapeutics Market, by Application, 2021–2030 (USD Million)
Table 29 North America: Digital Therapeutics Market, by End User, 2021–2030 (USD Million)
Table 30 U.S.: Digital Therapeutics Market, by Type, 2021–2030 (USD Million)
Table 31 U.S.: Digital Therapeutics Market, by Application, 2021–2030 (USD Million)
Table 32 U.S.: Digital Therapeutics Market, by End User, 2021–2030 (USD Million)
Table 33 Canada: Digital Therapeutics Market, by Type, 2021–2030 (USD Million)
Table 34 Canada: Digital Therapeutics Market, by Application, 2021–2030 (USD Million)
Table 35 Canada: Digital Therapeutics Market, by End User, 2021–2030 (USD Million)
Table 36 Europe: Digital Therapeutics Market, by Country/Region, 2021–2030 (USD Million)
Table 37 Europe: Digital Therapeutics Market, by Type, 2021–2030 (USD Million)
Table 38 Europe: Digital Therapeutics Market, by Application, 2021–2030 (USD Million)
Table 39 Europe: Digital Therapeutics Market, by End User, 2021–2030 (USD Million)
Table 40 Germany: Digital Therapeutics Market, by Type, 2021–2030 (USD Million)
Table 41 Germany: Digital Therapeutics Market, by Application, 2021–2030 (USD Million)
Table 42 Germany: Digital Therapeutics Market, by End User, 2021–2030 (USD Million)
Table 43 U.K.: Digital Therapeutics Market, by Type, 2021–2030 (USD Million)
Table 44 U.K.: Digital Therapeutics Market, by Application, 2021–2030 (USD Million)
Table 45 U.K.: Digital Therapeutics Market, by End User, 2021–2030 (USD Million)
Table 46 France: Digital Therapeutics Market, by Type, 2021–2030 (USD Million)
Table 47 France: Digital Therapeutics Market, by Application, 2021–2030 (USD Million)
Table 48 France: Digital Therapeutics Market, by End User, 2021–2030 (USD Million)
Table 49 Italy: Digital Therapeutics Market, by Type, 2021–2030 (USD Million)
Table 50 Italy: Digital Therapeutics Market, by Application, 2021–2030 (USD Million)
Table 51 Italy: Digital Therapeutics Market, by End User, 2021–2030 (USD Million)
Table 52 Spain: Digital Therapeutics Market, by Type, 2021–2030 (USD Million)
Table 53 Spain: Digital Therapeutics Market, by Application, 2021–2030 (USD Million)
Table 54 Spain: Digital Therapeutics Market, by End User, 2021–2030 (USD Million)
Table 55 Rest of Europe: Digital Therapeutics Market, by Type, 2021–2030 (USD Million)
Table 56 Rest of Europe: Digital Therapeutics Market, by Application, 2021–2030 (USD Million)
Table 57 Rest of Europe: Digital Therapeutics Market, by End User, 2021–2030 (USD Million)
Table 58 Asia-Pacific: Digital Therapeutics Market, by Country/Region, 2021–2030 (USD Million)
Table 59 Asia-Pacific: Digital Therapeutics Market, by Type, 2021–2030 (USD Million)
Table 60 Asia-Pacific: Digital Therapeutics Market, by Application, 2021–2030 (USD Million)
Table 61 Asia-Pacific: Digital Therapeutics Market, by End User, 2021–2030 (USD Million)
Table 62 China: Digital Therapeutics Market, by Type, 2021–2030 (USD Million)
Table 63 China: Digital Therapeutics Market, by Application, 2021–2030 (USD Million)
Table 64 China: Digital Therapeutics Market, by End User, 2021–2030 (USD Million)
Table 65 Japan: Digital Therapeutics Market, by Type, 2021–2030 (USD Million)
Table 66 Japan: Digital Therapeutics Market, by Application, 2021–2030 (USD Million)
Table 67 Japan: Digital Therapeutics Market, by End User, 2021–2030 (USD Million)
Table 68 India: Digital Therapeutics Market, by Type, 2021–2030 (USD Million)
Table 69 India: Digital Therapeutics Market, by Application, 2021–2030 (USD Million)
Table 70 India: Digital Therapeutics Market, by End User, 2021–2030 (USD Million)
Table 71 Rest of Asia-Pacific: Digital Therapeutics Market, By Type, 2021–2030 (USD Million)
Table 72 Rest of Asia-Pacific: Digital Therapeutics Market, by Application, 2021–2030 (USD Million)
Table 73 Rest of Asia-Pacific: Digital Therapeutics Market, by End User, 2021–2030 (USD Million)
Table 74 Latin America: Digital Therapeutics Market, by Country/Region, 2021–2030 (USD Million)
Table 75 Latin America: Digital Therapeutics Market, by Type, 2021–2030 (USD Million)
Table 76 Latin America: Digital Therapeutics Market, by Application, 2021–2030 (USD Million)
Table 77 Latin America: Digital Therapeutics Market, by End User, 2021–2030 (USD Million)
Table 78 Brazil: Digital Therapeutics Market, by Type, 2021–2030 (USD Million)
Table 79 Brazil: Digital Therapeutics Market, by Application, 2021–2030 (USD Million)
Table 80 Brazil: Digital Therapeutics Market, by End User, 2021–2030 (USD Million)
Table 81 Mexico: Digital Therapeutics Market, by Type, 2021–2030 (USD Million)
Table 82 Mexico: Digital Therapeutics Market, by Application, 2021–2030 (USD Million)
Table 83 Mexico: Digital Therapeutics Market, by End User, 2021–2030 (USD Million)
Table 84 People (20-79 Y) With Diabetes in Argentina, Colombia, and Chile (in Thousands)
Table 85 Rest of Latin America: Digital Therapeutics Market, by Type, 2021–2030 (USD Million)
Table 86 Rest of Latin America: Digital Therapeutics Market, by Application, 2021–2030 (USD Million)
Table 87 Rest of Latin America: Digital Therapeutics Market, by End User, 2021–2030 (USD Million)
Table 88 Middle East & Africa: Digital Therapeutics Market, by Type, 2021–2030 (USD Million)
Table 89 Middle East & Africa: Digital Therapeutics Market, by Application, 2021–2030 (USD Million)
Table 90 Middle East & Africa: Digital Therapeutics Market, by End User, 2021–2030 (USD Million)
Table 91 Recent Developments, by Company, 2020–2023
List of Figures
Figure 1 Market Ecosystem
Figure 2 Key Stakeholders
Figure 3 Research Process
Figure 4 Secondary Sources Referenced for this Study
Figure 5 Primary Research Techniques
Figure 6 Key Executives Interviewed
Figure 7 Breakdown of Primary Interviews (Supply-Side & Demand Side)
Figure 8 Market Sizing and Growth Forecast Approach
Figure 9 Global Digital Therapeutics Market Size, by Type, 2023 Vs. 2030 (USD Million)
Figure 10 Global Digital Therapeutics Market Size, by Application, 2023 Vs. 2030 (USD Million)
Figure 11 Global Digital Therapeutics Market Size, by End User, 2023 Vs. 2030 (USD Million)
Figure 12 Global Digital Therapeutics Market, by Geography
Figure 13 Global Digital Therapeutics Market: Impact Analysis
Figure 14 Germany: Reimbursement Approval Pathway
Figure 15 Global Digital Therapeutics Market, by Type, 2023 Vs. 2030 (USD Million)
Figure 16 Global Digital Therapeutics Market, by Applications, 2023 Vs. 2030 (USD Million)
Figure 17 Diabetes Patients, by Region 2021 Vs. 2030 Vs. 2045 (Million)
Figure 18 Drug Consumption Among the Population in 2020 (Million People)
Figure 19 Prevalence of Tobacco Use (% Of Adults) in 2020
Figure 20 Global Digital Therapeutics Market Size, by End User, 2023 Vs. 2030 (USD Million)
Figure 21 Digital Therapeutics Market, by Region, 2023 Vs. 2030 (USD Million)
Figure 22 North America: Digital Therapeutics Market Snapshot
Figure 23 U.S.: Number of People with Chronic Diseases, 2005-2030 (In Millions)
Figure 24 Europe: Digital Therapeutics Market Snapshot
Figure 25 Asia-Pacific: Digital Therapeutics Market Snapshot
Figure 26 Japan: Growth in Aging Population 2015-2021 (Million)
Figure 27 RoAPAC: Growth in Aging Population 2015 Vs. 2017 Vs. 2021 (Million)
Figure 28 Latin America: Digital Therapeutics Market Snapshot
Figure 29 Growth in the Elderly Population 2021 Vs. 2017 Vs. 2015
Figure 30 Key Growth Strategies Adopted by Leading Players, 2020–2023
Figure 31 Digital Therapeutics Market: Competitive Benchmarking (Based on Type)
Figure 32 Competitive Benchmarking for DTx: Based on DTx Capabilities and Therapeutic Area
Figure 33 Competitive Dashboard: Digital Therapeutics Market
Figure 34 Company Ranking: Digital Therapeutics Market (2022)
Figure 35 Resmed Inc.: Financial Snapshot (2022)
Figure 36 Teladoc Health, Inc.: Financial Overview (2022)
Figure 37 Dariohealth Corp.: Financial Snapshot (2022)
Figure 38 Akili, Inc.: Financial Snapshot (2022)